Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
12/2008
12/04/2008US20080301824 Parkin interacting polypeptides and methods of use
12/04/2008US20080301823 Polynucleotide for Producing Recombinant Protein in Silkworm
12/04/2008US20080301822 Role of alpha1-adrenergic receptors
12/04/2008US20080301821 Diagnostic and Therapeutic use of a Plasma Membrane Atpase
12/04/2008US20080300450 protecting a mammalian oocyte or embryo from embryotoxic effects by administering the prostaglandin F2 alpha receptor antagonist to a recipient female mammal; reduce transplant rejection when transfer oocyte or embryo in cattle
12/04/2008US20080300384 T-bet compositions and methods of use thereof
12/04/2008US20080300206 Alpha-Synuclein Kinase
12/04/2008US20080300202 Subtractive transgenics
12/04/2008US20080300184 Transgenic tieg non-human animals
12/04/2008US20080300183 Gastrointestinal proliferative factor and uses thereof
12/04/2008US20080299599 Fluorescent proteins for monitoring intracellular superoxide production
12/04/2008US20080299592 Red-Shifted Luciferase
12/04/2008US20080299548 polynucleotide having a homology of 95% or more with the polynucleotide specifically expressed in a mouse embryonic stem (ES) cell; used for the detection of an ES cell, screening for a somatic cell nuclear reprogramming substance, screening for a ES cell maintaining substance
12/04/2008US20080299128 prevent immune cells from binding to other cells by contacting the immune cells and the other cells with a composition with bone marrow stromal cell antigen 2 (Bst2) antagonist; antiinflamatory agents
12/04/2008US20080299125 Genetic basis of treatment response in depression patients
12/04/2008US20080299112 Human Polyclonal Antibodies from Genetically Engineered Animals
12/04/2008US20080299077 Isolation and growth of stem cells from hemangiomas
12/04/2008US20080295774 Automated Packaging, Inoculation, and Harvesting of Lepidopterous Larvae for Protein Manufacturing
12/04/2008CA2689695A1 Transgenic animals producing monovalent human antibodies and antibodies obtainable from these animals
12/04/2008CA2687609A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
12/03/2008EP1997895A1 Family of nucleic sequences and deduced protein sequences having human endogenous retroviral patterns, their flanking sequences and their applications
12/03/2008EP1997890A1 Chinese hamster apoptosis-related genes
12/03/2008EP1997512A2 Methods for treating TWEAK-related conditions
12/03/2008EP1996216A2 Methods to identify factors associated with muscle growth and uses thereof
12/03/2008EP1784482A4 Transgenic mammals and cell lines for the identification of glutamate transporter modulators
12/03/2008EP1575354B1 Melusin, a muscle specific protein, as a drug target for prevention and treatment of heart failure, and applications thereof
12/03/2008CN201159803Y Spectacles for chicken
12/03/2008CN101313667A Industrial production breed system for bumblebee
12/03/2008CN100439503C Variants of gamma chain of AMPK, DNA sequences encoding same, and uses thereof
12/03/2008CN100439500C Mouse model of hipatitis B virus gene positioning integration to result in liver cell callcer
12/02/2008US7460998 Voice connection system between humans and animals
12/02/2008US7459602 for breast, kidney, ovary and stomach cancers; comprises a probe having the nucleotide sequence complementary to mRNA transcribed from the human protooncogene (HCCR-1)
12/02/2008US7459601 Animal model for use in monitoring aggregation of alpha -synuclein non-amyloid component (NAC) and identifying agent for treatment of nervous system disorders; neuroprotective agents
12/02/2008US7459600 Isolation, selection and propagation of animal transgenic stem cells
12/02/2008US7459599 Methods for producing proteins using silkworm middle silk gland-specific gene expression system
12/02/2008US7459540 Fibroblast growth factor-like polypeptides
12/02/2008US7459291 Chordin-like molecules and uses thereof
11/2008
11/27/2008WO2008144142A1 Memory and learning impairments associated with disruption of ephrin receptor a6 (epha6) gene
11/27/2008WO2008143979A2 Tumor suppressor gene screening using rna interference libraries and method of treatment
11/27/2008WO2008143668A2 Indoleamine-2, 3-dioxygenase-2
11/27/2008WO2008008160A3 High efficiency flp site-specific recombination in mammalian cells using an optimized flp gene
11/27/2008WO2007124302A3 Bone graft composition
11/27/2008WO2007089946A3 Animal model for hiv induced disease
11/27/2008WO2006044612A3 Development of sensitive fret sensors and methods of using the same
11/27/2008US20080295192 Self-induced deletion of dna
11/27/2008US20080295191 Method for producing cloned dog
11/27/2008US20080295190 comprising a Cricetulus griseus ( FAIM, FADD, PDCD6 and Requiem) sequence capable of mediating apoptosis of cells
11/27/2008US20080295189 Construction of Arterial Occlusive Disease Animal Model
11/27/2008US20080295188 administering a Toll-like receptor ligand such as polyinosinic-polycytidylic acid into the peritoneal cavity of an animal with a food or drink test substance, to see if it increases NK cell proliferation; harvesting NK cells from peritoneal cavity of animal
11/27/2008US20080295187 Accessing the Toxic Potential of Nanomaterials
11/27/2008US20080295186 Neurotrypsin overexpressing animal
11/27/2008US20080295185 Transgenic Mouse Models of Hepatitis C Virus (Hcv) and Identification of Hvc Therapeutics
11/27/2008US20080292753 Polypeptides Having Phytase Activity and Polynucleotides Encoding Same
11/27/2008US20080292647 immunogenic protein in a biodrug, was encoded from an isolated host cell transfected with the recombinant expression vector; anticarcinogenic agent for treating skin cancer; vaccine for prevention and treatment; immunotherapy
11/27/2008US20080292644 Compositions and methods for identifying response targets and treating flavivirus infection responses
11/27/2008US20080292615 Diagnosis and treatment of disease
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292591 localized foci of model tumor cells highly correlated to actual clinical tumor cells; genetic engineering; drug screening
11/27/2008CA2687844A1 Tumor suppressor gene screening using rna interference libraries and method of treatment
11/26/2008EP1995321A2 Gene disruptions, compositions and methods relating thereto
11/26/2008EP1995315A2 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
11/26/2008EP1995255A1 Truncated tau proteins
11/26/2008EP1994824A1 Chimeric non-human animal
11/26/2008EP1993597A2 Human telomerase reverse transcriptase peptides
11/26/2008EP1699289B1 Non-human mammal comprising a modified serca2 gene and methods, cells, genes, and vectors thereof
11/26/2008EP1515752B1 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
11/26/2008EP1434592B1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
11/26/2008EP1298988B1 Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on intracellular receptors, and method for the preparation thereof
11/26/2008CN201153451Y Angleworm biology environmental protection vehicle
11/26/2008CN101310591A Modern system agricultural industry system designed according to material and energy cycle
11/26/2008CN100435630C Cynoglossus semilaevis ovum miosis gynogenesis method induced by bass frozen sperm
11/25/2008US7456333 Transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem calls.
11/25/2008US7455988 Nucleotide sequences; genetic engineering; controller fusion protein; blocking transcription
11/25/2008US7455962 Obtaining cells from the aorta-gonad-mesonephros region, detecting cells comprising a podocalyxin-like protein 1-positive phenotype (e.g., using an anti-PCLP1 antibody) and isolating them, and identifying from the isolated cells those having a CD45-negative phenotype
11/20/2008WO2008140502A2 Surgically implanted micro-platforms and microsystems in arthropods and methods based thereon
11/20/2008WO2008140126A1 Single-stranded cyclic rna, and method for production thereof
11/20/2008WO2008139259A2 Fluorescent proteins for monitoring intracellular superoxide production
11/20/2008WO2008121199A3 Transgenic animal models of disease
11/20/2008WO2008088863A9 Stem cell gene targeting
11/20/2008WO2008027241A3 Non-human embryonic stem cell lines and transgenic animals derived from them
11/20/2008WO2008021393A3 Orthotopic, controllable, and genetically tractable non-human animal model for cancer
11/20/2008WO2008008874A3 Modulators of rnf5 and uses thereof
11/20/2008WO2005058025A3 Renewably buoyant, self-protective floating habitat
11/20/2008US20080289059 Methods for developing animal models
11/20/2008US20080289058 Targeted delivery of glycine receptors to excitable cells
11/20/2008US20080289057 Sperm factor sequences
11/20/2008US20080289056 Aldolases, nucleic acids encoding them; improving thermal stability of enzyme; biosynthesis of atorvastatin, rosuvastatin, fluvastatin starting from e.g. acetaldehyde and chloroacetaldehyde, using enzyme 2-deoxyribose-5-phosphate aldolase (DERA) to form pyran intermediate
11/20/2008US20080289055 Melanoma antigens and their use in diagnostic and therapeutic methods
11/20/2008US20080289054 Fish Cancer Model
11/20/2008US20080289053 Methods and systems for identifying modulators of longevity
11/20/2008US20080289052 Method of Constructing Animal Having Cancer Cells Transplanted Thereinto
11/20/2008US20080287651 Silk Thread Containing Spider Thread Protein and Silk Worm Producing the Silk Thread
11/20/2008US20080287364 Bitter Taste Receptors
11/20/2008US20080287363 Isolated from the saliva of Rhipicephalus sanguineus; antiinflammatory and immunomodulatory compounds; antagonists of CCL5 and CCL11
11/20/2008US20080287348 Soluble Hybrid Prion Proteins And Their Use In The Diagnosis, Prevention And Treatment Of Transmissible Spongiform Encephalopathies
11/20/2008US20080286813 Antibody specific for mutant presenilin 1 and method of use thereof
11/20/2008US20080286804 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy
11/20/2008US20080286760 Means and Methods for the Determination of Camp In Vitro and In Vivo
11/20/2008US20080286415 Proteases
11/20/2008US20080286350 Formulation of Multivalent Antibody Constructs and Use of Same for Cancer Therapy